APA (7th ed.) Citation

Moreno, S., Rivero, A., Ventayol, P., Falcó, V., Torralba, M., Schroeder, M., . . . Harrison, C. (2023). Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain. Infectious Diseases & Therapy, 12(8), 2039. https://doi.org/10.1007/s40121-023-00840-y

Chicago Style (17th ed.) Citation

Moreno, Santiago, et al. "Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months Is Cost-Effective for the Treatment of HIV-1 in Spain." Infectious Diseases & Therapy 12, no. 8 (2023): 2039. https://doi.org/10.1007/s40121-023-00840-y.

MLA (9th ed.) Citation

Moreno, Santiago, et al. "Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months Is Cost-Effective for the Treatment of HIV-1 in Spain." Infectious Diseases & Therapy, vol. 12, no. 8, 2023, p. 2039, https://doi.org/10.1007/s40121-023-00840-y.